Stocks · Health care · Pharmaceutical Preparations

Biohaven Ltd.

BHVN Clue Score30

United States Fiscal year ends December CIK 0001935979 Results filed 29 Oct 2026

Add to watchlist

What the insiders did Net buying

By person

8 insiders · 5 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

John W Childs

Director

$25.00M (1)

—

+$25.00M

5,653,904

3.74%

$48.15M

+150.3%

Vlad Coric

Chief Executive Officer

$5.00M (2)

—

+$5.00M

2,544,514

1.68%

$21.67M

+36.5%

Gregory Bailey

Director

$3.00M (1)

—

+$3.00M

2,020,071

1.34%

$17.20M

+24.7%

George C. Clark

VP, Chief Accounting Officer

$144.77K (1)

—

+$144.77K

86,978

0.0576%

$740.70K

+29.4%

Matthew Buten

Chief Financial Officer

—

—

—

195,652

0.1295%

$1.67M

+1.7%

Kimberly Gentile

SVP, Clinical Operations

—

—

—

99,557

0.0659%

$847.82K

+3.7%

Kishan Mehta

Director

—

—

—

22,662

0.0150%

$192.99K

0.0%

Bruce Car

Chief Scientific Officer

—

—

—

7,715

0.0051%

$65.70K

+163.6%